In 2018, a New York surgeon-scientist and his team demonstrated in a proof-of-concept study that a minimally invasive procedure could effectively treat one of the world's most common conditions ...

For patients with chronic subdural hematoma, a 19-day tapering course of dexamethasone therapy is not noninferior to surgery with respect to functional outcomes at three months, according to a study ...